首页> 外文OA文献 >Enantioselective Determination of Ondansetron and 8-Hydroxyondansetron in Human Plasma from Recovered Surgery Patients by Liquid Chromatography-Tandem Mass Spectrometry
【2h】

Enantioselective Determination of Ondansetron and 8-Hydroxyondansetron in Human Plasma from Recovered Surgery Patients by Liquid Chromatography-Tandem Mass Spectrometry

机译:液相色谱-串联质谱法对回收手术患者血浆中的恩丹西酮和8-羟基丹参酮进行对映选择性测定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A liquid chromatographic-mass spectrometric assay with atmospheric pressure chemical ionization for quantification of ondansetron and its main metabolite 8-hydroxyondansetron in human plasma was presented. The enantiomeric separation was achieved on a Chiralcel OD-R column containing cellulose tris-(3,5-dimethylphenylcarbamate). The validation data were within the required limits. The assay was successfully applied to authentic plasma samples. Quantitative results from postoperative patients receiving ondansetron demonstrated a great interindividual variability in postoperative plasma drug concentrations, the metabolites were not detected in their unconjugated form. A wide variation in the S-(+)-/R-(−)-ondansetron concentration ratio between 0.14 and 7.18 is indicative for a stereoselective disposition or metabolism. In further studies CYP2D6 and CYP3A4 genotype dependent metabolism of ondansetron enantiomers as well as of co-administered drugs and clinical efficacy of the medication should be tested
机译:提出了一种采用大气压化学电离的液相色谱-质谱联用法测定人血浆中恩丹西酮及其主要代谢物8-羟基恩丹西酮的方法。在含有纤维素三(3,5-二甲基苯基氨基甲酸酯)的Chiralcel OD-R柱上完成对映体分离。验证数据在要求的范围内。该测定法已成功应用于真实的血浆样品。接受恩丹西酮的术后患者的定量结果表明,术后血浆药物浓度存在很大的个体差异,未检测到未结合形式的代谢物。 S-(+)-/ R-(-)-恩丹西酮浓度比在0.14和7.18之间的宽幅变化表示立体选择性处置或新陈代谢。在进一步的研究中,恩丹西酮对映体以及共同给药药物的CYP2D6和CYP3A4基因型依赖性代谢和药物的临床疗效应进行测试

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号